tiprankstipranks
Trending News
More News >

Protara Therapeutics expects cash to fund operations into 2025

As of June 30, 2023, cash, cash equivalents and restricted cash were $80.4 million. The Company expects its current cash and cash equivalents will be sufficient to fund its planned operations into 2025.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on TARA:

Disclaimer & DisclosureReport an Issue